Dr.wu Skincare (6523) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 達爾膚

Dr.wu Skincare (6523) reported revenue of NT$95.3 million for Oct 2026, +30.0% year on year and +36.1% from the previous month. Revenue for Jan–Oct 2026 was NT$856.9 million (-11.4% year on year).

In Oct 2026, it ranked No. 77 by revenue among 160 Biotech & Medical companies.

Next ex-date: 2026-11-26 (Cash dividend, cash per share NT$4) Taiwan ex-dividend calendar →

Monthly revenue chart

Oct 2024 NT$127.8 million24/10Nov 2024 NT$139.9 millionDec 2024 NT$74.8 millionJan 2025 NT$121.9 millionFeb 2025 NT$78.4 million25/02Mar 2025 NT$146.7 millionApr 2025 NT$66.5 millionMay 2025 NT$65.8 millionJun 2025 NT$93.3 million25/06Jul 2025 NT$89.4 millionAug 2025 NT$150.5 millionSep 2025 NT$80.9 millionOct 2025 NT$73.3 million25/10Nov 2025 NT$114 millionDec 2025 NT$87.5 millionJan 2026 NT$89.9 millionFeb 2026 NT$106.7 million26/02Mar 2026 NT$79.8 millionApr 2026 NT$61.1 millionMay 2026 NT$54.8 millionJun 2026 NT$87 million26/06Jul 2026 NT$83 millionAug 2026 NT$129.3 millionSep 2026 NT$70.1 millionOct 2026 NT$95.3 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$95.3 million+30.0%+36.1%
Sep 2026NT$70.1 million-13.4%-45.8%
Aug 2026NT$129.3 million-14.0%+55.9%
Jul 2026NT$83 million-7.2%-4.7%
Jun 2026NT$87 million-6.8%+58.8%
May 2026NT$54.8 million-16.8%-10.2%
Apr 2026NT$61.1 million-8.1%-23.5%
Mar 2026NT$79.8 million-45.6%-25.2%
Feb 2026NT$106.7 million+36.1%+18.7%
Jan 2026NT$89.9 million-26.3%+2.8%
Dec 2025NT$87.5 million+16.9%-23.3%
Nov 2025NT$114 million-18.5%+55.5%
Oct 2025NT$73.3 million-42.6%-9.3%
Sep 2025NT$80.9 million+2.2%-46.3%
Aug 2025NT$150.5 million+16.6%+68.3%
Jul 2025NT$89.4 million-6.9%-4.2%
Jun 2025NT$93.3 million-8.7%+41.8%
May 2025NT$65.8 million-9.1%-1.0%
Apr 2025NT$66.5 million-6.6%-54.7%
Mar 2025NT$146.7 million+4.5%+87.2%
Feb 2025NT$78.4 million-15.7%-35.7%
Jan 2025NT$121.9 million+5.2%+63.0%
Dec 2024NT$74.8 million-24.6%-46.5%
Nov 2024NT$139.9 million+5.0%+9.5%
Oct 2024NT$127.8 million+33.9%+61.5%

Jan–Oct 2026 cumulative: NT$856.9 million (-11.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Dr.wu Skincare vs PEC / Dr.wu Skincare vs Lotus Pharm / Dr.wu Skincare vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16